A Crook family who lost their baby boy to a heart defect in 2019 feel history is repeating itself after their newborn son was ...

A patent ductus arteriosus (PDA) is seen in ∼ 65% of infants born at <28 wk of gestation . Infants with PDA are often treated with cyclooxygenase inhibitors to promote ductal closure.

AIM To compare the efficacy and safety of an indomethacin treatment strategy based on serial echocardiographic measurement of patent ductus arteriosus (PDA) flow pattern with a standard protocol.

Seven cases of patent ductus arteriosus with pulmonary hypertension and reversal of the usual direction of flow are described. Breathing of a low oxygen mixture either initiated or increased the ...

Background and aims Ibuprofen is the drug of first choice to close a patent ductus arteriosus (PDA) in preterm neonates. The most commonly used 10–5–5 mg/kg/3days bolus dosing schedule is only ...

A 7-month-old girl, ex-preterm (26-weeker), 4.5 kg, with 4 mm patent ductus arteriosus (PDA) underwent PDA device closure (Amplatzer duct occluder - ADO II 4×6 mm) elsewhere and was readmitted 4 days ...

Senate passes a bill that would prevent pharma firms from building patent thickets to delay biosimilar competitors to biologics. Skip to main content Sunday 29 June 2025 . BlueSky linkedin ...

The case – heard in a Delaware district court – was focused on US Patent No. 10,842,780 covering extended-release formulations of mirabegron that isn’t due to expire until 2030.

U.S. Government’s Intervention in Patent Case Signals Good News for Patent Owners Seeking Injunctions. Earlier today the United States filed a Statement of Interest in Radian Memory Systems, LLC v.